NCT03665506View on ClinicalTrials.gov

Trifluridin/tipirACil in MeTastatIc Colorectal Cancer

CompletedOBSERVATIONAL
Enrollment

315

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

August 2, 2021

Study Completion Date

August 2, 2021

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Trifluridin/Tipiracil

QoL assessment

Trial Locations (1)

10707

Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin

All Listed Sponsors
collaborator

iOMEDICO AG

INDUSTRY

lead

Servier

INDUSTRY

NCT03665506 - Trifluridin/tipirACil in MeTastatIc Colorectal Cancer | Biotech Hunter | Biotech Hunter